Letter to the Editor Authors Paolo A. Ascierto Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli, Italy DOI: https://doi.org/10.19156/cbn.2017.0040 Abstract No abstract available